{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:42:24Z","timestamp":1788950544855,"version":"build-2803163510"},"reference-count":20,"publisher":"American Diabetes Association","issue":"10","license":[{"start":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T00:00:00Z","timestamp":1758240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.diabetesjournals.org\/journals\/pages\/license"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R24 AI067039"],"award-info":[{"award-number":["R24 AI067039"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UAB CFAR Grant P30 AI027767"],"award-info":[{"award-number":["UAB CFAR Grant P30 AI027767"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UNC CFAR Grant P30 AI50410"],"award-info":[{"award-number":["UNC CFAR Grant P30 AI50410"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["UW CFAR NIAID Grant P30 AI027757"],"award-info":[{"award-number":["UW CFAR NIAID Grant P30 AI027757"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01HL126538"],"award-info":[{"award-number":["R01HL126538"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA047045"],"award-info":[{"award-number":["R01DA047045"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA058938"],"award-info":[{"award-number":["R01DA058938"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE<\/jats:title>\n                    <jats:p>To evaluate semaglutide use among people with HIV (PWH) with medical indications by race and ethnicity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                    <jats:p>We identified PWH in the Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) cohort at nine sites eligible for semaglutide therapy between 2019 and 2023. Semaglutide eligibility was based on BMI \u226530 or HbA1c \u22656.5. We evaluated differences in semaglutide receipt among eligible PWH by race and ethnicity using relative risk regression adjusted for demographic characteristics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS<\/jats:title>\n                    <jats:p>Among 11,617 eligible PWH, 774 (6.7%) received semaglutide (92% eligible by BMI \u226530, 62% by HbA1c \u22656.5, and 54% by both criteria). Eligible Black PWH were 20% less likely to receive semaglutide versus White PWH (prevalence ratio [PR] 0.80, 95% CI 0.67\u20130.95). The lower rate of semaglutide for Black (PR 0.66, 95% CI 0.53\u20130.83) and Hispanic PWH (PR 0.70, 95% CI 0.53\u20130.93) was more pronounced among those with higher HbA1c (\u22658.0).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSIONS<\/jats:title>\n                    <jats:p>We describe inequitable semaglutide use among PWH, with lower initiation rates in eligible Black PWH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2337\/dc25-0236","type":"journal-article","created":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T19:02:24Z","timestamp":1758308544000},"page":"1761-1765","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":3,"title":["Racial Inequity in Prescription of Semaglutide Among Eligible People With HIV"],"prefix":"10.2337","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9552-1700","authenticated-orcid":false,"given":"Andrew W.","family":"Hahn","sequence":"first","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Ruderman","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.M.","family":"Nance","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.M.","family":"Whitney","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Eltonsy","sequence":"additional","affiliation":[{"name":"University of Manitoba, Winnipeg 2 , Manitoba, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Haidar","sequence":"additional","affiliation":[{"name":"University of Manitoba, Winnipeg 2 , Manitoba, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.N.","family":"Drumright","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Ma","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.H.","family":"Mayer","sequence":"additional","affiliation":[{"name":"The Fenway Institute, Harvard Medical School 3 , Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Napravnik","sequence":"additional","affiliation":[{"name":"University of North Carolina 4 , Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.J.","family":"Eron","sequence":"additional","affiliation":[{"name":"University of North Carolina 4 , Chapel Hill, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.A.","family":"Christopoulos","sequence":"additional","affiliation":[{"name":"University of California San Francisco 5 , San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Bamford","sequence":"additional","affiliation":[{"name":"University of California San Diego 6 , La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.R.","family":"Cachay","sequence":"additional","affiliation":[{"name":"University of California San Diego 6 , La Jolla, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Yendewa","sequence":"additional","affiliation":[{"name":"Case Western University 7 , Cleveland, OH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Pettit","sequence":"additional","affiliation":[{"name":"Vanderbilt University 8 , Nashville, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Saag","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham 9 , Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Heath","sequence":"additional","affiliation":[{"name":"University of Alabama at Birmingham 9 , Birmingham, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.D.","family":"Moore","sequence":"additional","affiliation":[{"name":"Johns Hopkins University 10 , Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.C.","family":"Keruly","sequence":"additional","affiliation":[{"name":"Johns Hopkins University 10 , Baltimore, MD"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.S.","family":"Batey","sequence":"additional","affiliation":[{"name":"Tulane University 11 , New Orleans, LA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Chander","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.","family":"Kitahata","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.C.","family":"Delaney","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.M.","family":"Crane","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.J.","family":"Fredericksen","sequence":"additional","affiliation":[{"name":"University of Washington 1 , Seattle, WA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2025,9,19]]},"reference":[{"key":"2026061714370644300_B1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/COH.0000000000000834","article-title":"The pathogenesis of obesity in people living with HIV","volume":"19","author":"Bailin","year":"2024","journal-title":"Curr Opin HIV AIDS"},{"key":"2026061714370644300_B2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1093\/cid\/ciad545","article-title":"Weight gain after antiretroviral therapy initiation and subsequent risk of metabolic and cardiovascular disease","volume":"78","author":"Bares","year":"2024","journal-title":"Clin Infect Dis"},{"key":"2026061714370644300_B3","first-page":"201","article-title":"Racial disparities in HIV care extend to common comorbidities: implications for implementation of interventions to reduce disparities in HIV care","volume":"108","author":"Richardson","year":"2016","journal-title":"J Natl Med Assoc"},{"key":"2026061714370644300_B4","doi-asserted-by":"crossref","first-page":"2325958220904241","DOI":"10.1177\/2325958220904241","article-title":"The intersection of HIV, diabetes, and race: exploring disparities in diabetes care among people living with HIV","volume":"19","author":"Galaviz","year":"2020","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"2026061714370644300_B5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.3851\/IMP2450","article-title":"Disparities in prevalence of key chronic diseases by gender and race\/ethnicity among antiretroviral-treated HIV-infected adults in the US","volume":"18","author":"Buchacz","year":"2013","journal-title":"Antivir Ther"},{"key":"2026061714370644300_B6","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1089\/aid.2015.0062","article-title":"Obesity is associated with race\/sex disparities in diabetes and hypertension prevalence, but not cardiovascular disease, among HIV-infected adults","volume":"31","author":"Willig","year":"2015","journal-title":"AIDS Res Hum Retroviruses"},{"key":"2026061714370644300_B7","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clinthera.2023.12.014","article-title":"Use of dulaglutide, semaglutide, and tirzepatide in diabetes and weight management","volume":"46","author":"Powell","year":"2024","journal-title":"Clin Ther"},{"key":"2026061714370644300_B8","doi-asserted-by":"crossref","first-page":"e025545","DOI":"10.1161\/JAHA.121.025545","article-title":"Racial and ethnic disparities in financial barriers among overweight and obese adults eligible for semaglutide in the United States","volume":"11","author":"Lu","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026061714370644300_B9","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1111\/j.1475-6773.2006.00682.x","article-title":"Utilizing new prescription drugs: disparities among non-Hispanic whites, non-Hispanic blacks, and Hispanic whites","volume":"42","author":"Wang","year":"2007","journal-title":"Health Serv Res"},{"key":"2026061714370644300_B10","doi-asserted-by":"crossref","first-page":"ofab338","DOI":"10.1093\/ofid\/ofab338","article-title":"Integrase inhibitor prescribing disparities in the DC and Johns Hopkins HIV cohorts","volume":"8","author":"Monroe","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"2026061714370644300_B11","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1007\/s11606-022-07428-1","article-title":"Racial and ethnic inequities in diabetes pharmacotherapy: Black and Hispanic patients are less likely to receive SGLT2is and GLP1as","volume":"37","author":"Cai","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2026061714370644300_B12","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc22-0383","article-title":"Deficits and disparities in early uptake of glucagon-like peptide 1 receptor agonists and SGLT2i among Medicare-insured adults following a new diagnosis of cardiovascular disease or heart failure","volume":"46","author":"Cromer","year":"2023","journal-title":"Diabetes Care"},{"key":"2026061714370644300_B13","doi-asserted-by":"crossref","first-page":"e214182","DOI":"10.1001\/jamahealthforum.2021.4182","article-title":"Racial, ethnic, and socioeconomic inequities in glucagon-like peptide-1 receptor agonist use among patients with diabetes in the US","volume":"2","author":"Eberly","year":"2021","journal-title":"JAMA Health Forum"},{"key":"2026061714370644300_B14","first-page":"100111","article-title":"Racial\/ethnic and socioeconomic disparities in the use of newer diabetes medications in the Look AHEAD study","volume":"6","author":"Elhussein","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2026061714370644300_B15","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ije\/dym231","article-title":"Cohort profile: the Centers for AIDS Research Network of Integrated Clinical Systems","volume":"37","author":"Kitahata","year":"2008","journal-title":"Int J Epidemiol"},{"key":"2026061714370644300_B16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified Poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"2026061714370644300_B17","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/QAI.0b013e3181845589","article-title":"Discrimination, distrust, and racial\/ethnic disparities in antiretroviral therapy adherence among a national sample of HIV-infected patients","volume":"49","author":"Thrasher","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2026061714370644300_B18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bodyim.2009.11.002","article-title":"Ethnic and racial differences in body size perception and satisfaction","volume":"7","author":"Kronenfeld","year":"2010","journal-title":"Body Image"},{"key":"2026061714370644300_B19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/M16-2596","article-title":"Racial differences in the relationship of glucose concentrations and hemoglobin A1c levels","volume":"167","author":"Bergenstal","year":"2017","journal-title":"Ann Intern Med"},{"key":"2026061714370644300_B20","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2174\/157016206775197637","article-title":"Diabetes case identification methods applied to electronic medical record systems: their use in HIV-infected patients","volume":"4","author":"Crane","year":"2006","journal-title":"Curr HIV Res"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/10\/1761\/841866\/dc250236.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/48\/10\/1761\/841866\/dc250236.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:37:17Z","timestamp":1781721437000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/48\/10\/1761\/163432\/Racial-Inequity-in-Prescription-of-Semaglutide"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,19]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,9,19]]},"published-print":{"date-parts":[[2025,10,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc25-0236","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,19]]}}}